189 related articles for article (PubMed ID: 36660631)
1. Ferroptosis-related genes with post-transcriptional regulation mechanisms in hepatocellular carcinoma determined by bioinformatics and experimental validation.
Zhu R; Gao C; Feng Q; Guan H; Wu J; Samant H; Yang F; Wang X
Ann Transl Med; 2022 Dec; 10(24):1390. PubMed ID: 36660631
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of ferroptosis-related genes for clinical and biological significance in hepatocellular carcinoma.
Wu Q; Tan Z; Xiong Y; Gu C; Zhou J; Yang H; Zhou J
Discov Oncol; 2023 May; 14(1):69. PubMed ID: 37198416
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
4. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
5. Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma.
Kang X; Huo Y; Jia S; He F; Li H; Zhou Q; Chang N; Liu D; Li R; Hu Y; Zhang P; Xu A
Front Oncol; 2022; 12():939605. PubMed ID: 35875091
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
Dai T; Li J; Lu X; Ye L; Yu H; Zhang L; Deng M; Zhu S; Liu W; Wang G; Yang Y
Pharmgenomics Pers Med; 2021; 14():927-945. PubMed ID: 34377010
[TBL] [Abstract][Full Text] [Related]
7. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.
Du X; Zhang Y
Front Genet; 2020; 11():614888. PubMed ID: 33391356
[TBL] [Abstract][Full Text] [Related]
9. Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis.
Yan X; Liu Y; Li C; Mao X; Xu T; Hu Z; Zhang C; Lin N; Lin Y; Zhang Y
Cancer Cell Int; 2023 Jun; 23(1):109. PubMed ID: 37280673
[TBL] [Abstract][Full Text] [Related]
10. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells.
LoBianco FV; Krager KJ; Johnson E; Godwin CO; Allen AR; Crooks PA; Compadre CM; Borrelli MJ; Aykin-Burns N
Front Toxicol; 2022; 4():936149. PubMed ID: 36591540
[TBL] [Abstract][Full Text] [Related]
12. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
Front Immunol; 2022; 13():929089. PubMed ID: 35874689
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.
Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
J Gastrointest Oncol; 2021 Oct; 12(5):2345-2360. PubMed ID: 34790397
[TBL] [Abstract][Full Text] [Related]
14. Novel prognostic signature based on HRAS, MAPK3 and TFRC identified to be associated with ferroptosis and the immune microenvironment in hepatocellular carcinoma.
Sun H; Qian X; Yang W; Zhou W; Zhou C; Liu S; Shi H; Tian W
Am J Transl Res; 2022; 14(10):6924-6940. PubMed ID: 36398204
[TBL] [Abstract][Full Text] [Related]
15. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
[TBL] [Abstract][Full Text] [Related]
18. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
Front Oncol; 2021; 11():657723. PubMed ID: 34485112
[TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma.
Luo L; Yao X; Xiang J; Huang F; Luo H
Sci Rep; 2022 Jun; 12(1):10007. PubMed ID: 35705729
[TBL] [Abstract][Full Text] [Related]
20. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
